Our Insights Oncology, R&D Insights Anthony Iannacci 11/11/25 Oncology, R&D Insights Anthony Iannacci 11/11/25 How Equinox Group Models Drugs in R&D: The Case of Alecensa in 1L ALK+ NSCLC Read More Chronic Disease Anthony Iannacci 3/20/24 Chronic Disease Anthony Iannacci 3/20/24 Xolair for food allergies: effective therapy at a high price Read More
Oncology, R&D Insights Anthony Iannacci 11/11/25 Oncology, R&D Insights Anthony Iannacci 11/11/25 How Equinox Group Models Drugs in R&D: The Case of Alecensa in 1L ALK+ NSCLC Read More
Chronic Disease Anthony Iannacci 3/20/24 Chronic Disease Anthony Iannacci 3/20/24 Xolair for food allergies: effective therapy at a high price Read More
